Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001013762-23-005521
Filing Date
2023-10-20
Accepted
2023-10-20 17:12:34
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_bluewater.htm   iXBRL 10-Q 1004438
2 FORM OF AMENDMENT, DATED OCTOBER 5, 2023, TO ASSET PURCHASE AGREEMENT, DATED JUN f10q0623ex10-14_bluewater.htm EX-10.14 124758
3 CERTIFICATION f10q0623ex31-1_bluewater.htm EX-31.1 12164
4 CERTIFICATION f10q0623ex31-2_bluewater.htm EX-31.2 12144
5 CERTIFICATION f10q0623ex32-1_bluewater.htm EX-32.1 4989
6 CERTIFICATION f10q0623ex32-2_bluewater.htm EX-32.2 5299
  Complete submission text file 0001013762-23-005521.txt   5547448

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bwv-20230630.xsd EX-101.SCH 61819
8 XBRL CALCULATION FILE bwv-20230630_cal.xml EX-101.CAL 35415
9 XBRL DEFINITION FILE bwv-20230630_def.xml EX-101.DEF 265593
10 XBRL LABEL FILE bwv-20230630_lab.xml EX-101.LAB 541015
11 XBRL PRESENTATION FILE bwv-20230630_pre.xml EX-101.PRE 281902
66 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_bluewater_htm.xml XML 497341
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Blue Water Biotech, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 231337732
SIC: 2834 Pharmaceutical Preparations